3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Methotrexate
2
thymoglobulin
1
siltuximab
1
duvelisib
1
cc-486
1
calaspargase pegol
1
blinatumomab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Thiotepa
1
Therapeutics
1
Thalidomide
1
Tacrolimus
1
Radiotherapy
1
Prednisone
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Interleukin-6
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Ganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Large Granular Lymphocytic
×
sargramostim
×
1 year
×
Clear all
No trials found.